

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of mononuclear cell migration (GO:0071675) | 4.42762250 |
| 2 | regulation of fever generation (GO:0031620) | 3.97789193 |
| 3 | positive regulation of heat generation (GO:0031652) | 3.81077171 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.55600581 |
| 5 | negative regulation of interleukin-12 production (GO:0032695) | 3.50849959 |
| 6 | locomotory exploration behavior (GO:0035641) | 3.45970878 |
| 7 | virion attachment to host cell (GO:0019062) | 3.42704959 |
| 8 | adhesion of symbiont to host cell (GO:0044650) | 3.42704959 |
| 9 | synaptic vesicle maturation (GO:0016188) | 3.37220631 |
| 10 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.35012963 |
| 11 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.33892208 |
| 12 | regulation of macrophage chemotaxis (GO:0010758) | 3.33292539 |
| 13 | adhesion of symbiont to host (GO:0044406) | 3.22649542 |
| 14 | regulation of heat generation (GO:0031650) | 3.17607787 |
| 15 | glycosphingolipid catabolic process (GO:0046479) | 3.16116469 |
| 16 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.14613358 |
| 17 | T-helper 1 type immune response (GO:0042088) | 3.05185775 |
| 18 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.01545729 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.00608708 |
| 20 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.99377098 |
| 21 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94500014 |
| 22 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.91717404 |
| 23 | sodium ion export (GO:0071436) | 2.91514998 |
| 24 | positive regulation of type 2 immune response (GO:0002830) | 2.89441885 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 2.88907265 |
| 26 | oligosaccharide catabolic process (GO:0009313) | 2.88519558 |
| 27 | axon extension involved in axon guidance (GO:0048846) | 2.86099509 |
| 28 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.86099509 |
| 29 | proline transport (GO:0015824) | 2.85537947 |
| 30 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.85356878 |
| 31 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.82149082 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 2.80706686 |
| 33 | glycolipid catabolic process (GO:0019377) | 2.79127356 |
| 34 | positive regulation of macrophage cytokine production (GO:0060907) | 2.77537727 |
| 35 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.73130048 |
| 36 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.72880476 |
| 37 | regulation of podosome assembly (GO:0071801) | 2.72782418 |
| 38 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.72674686 |
| 39 | regulation of vitamin metabolic process (GO:0030656) | 2.69320274 |
| 40 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.68964686 |
| 41 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.68427808 |
| 42 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.67662225 |
| 43 | barbed-end actin filament capping (GO:0051016) | 2.66407831 |
| 44 | response to peptidoglycan (GO:0032494) | 2.64494475 |
| 45 | regulation of synapse structural plasticity (GO:0051823) | 2.64421531 |
| 46 | apoptotic cell clearance (GO:0043277) | 2.63936178 |
| 47 | type I interferon signaling pathway (GO:0060337) | 2.63275824 |
| 48 | cellular response to type I interferon (GO:0071357) | 2.63275824 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61262083 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 2.59779764 |
| 51 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.58490511 |
| 52 | response to type I interferon (GO:0034340) | 2.58382034 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.53364158 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53364158 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 2.53364158 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 2.53364158 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 2.53364158 |
| 58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53364158 |
| 59 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.52579008 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.51710207 |
| 61 | vocalization behavior (GO:0071625) | 2.51000184 |
| 62 | cell communication by electrical coupling (GO:0010644) | 2.50885610 |
| 63 | myeloid dendritic cell differentiation (GO:0043011) | 2.48148911 |
| 64 | ceramide catabolic process (GO:0046514) | 2.46841118 |
| 65 | glutamate secretion (GO:0014047) | 2.46393335 |
| 66 | synaptic vesicle exocytosis (GO:0016079) | 2.45042597 |
| 67 | potassium ion import (GO:0010107) | 2.44933899 |
| 68 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.44853317 |
| 69 | monocyte chemotaxis (GO:0002548) | 2.43651133 |
| 70 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.41999296 |
| 71 | regulation of type 2 immune response (GO:0002828) | 2.41285082 |
| 72 | clathrin coat assembly (GO:0048268) | 2.41277430 |
| 73 | keratan sulfate catabolic process (GO:0042340) | 2.40157141 |
| 74 | regulation of interferon-alpha production (GO:0032647) | 2.40136805 |
| 75 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.38796691 |
| 76 | cellular response to lipopolysaccharide (GO:0071222) | 2.37915537 |
| 77 | germinal center formation (GO:0002467) | 2.36345856 |
| 78 | alanine transport (GO:0032328) | 2.36182807 |
| 79 | exploration behavior (GO:0035640) | 2.35323459 |
| 80 | regulation of chemokine biosynthetic process (GO:0045073) | 2.34479760 |
| 81 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.34328416 |
| 82 | activation of protein kinase A activity (GO:0034199) | 2.34072364 |
| 83 | amino sugar catabolic process (GO:0046348) | 2.33383375 |
| 84 | stress fiber assembly (GO:0043149) | 2.32068853 |
| 85 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.31276365 |
| 86 | plasma membrane repair (GO:0001778) | 2.30224840 |
| 87 | Rap protein signal transduction (GO:0032486) | 2.30087339 |
| 88 | positive regulation of fibroblast migration (GO:0010763) | 2.30044640 |
| 89 | negative regulation of lipid storage (GO:0010888) | 2.29481936 |
| 90 | response to thyroid hormone (GO:0097066) | 2.28536810 |
| 91 | cellular response to molecule of bacterial origin (GO:0071219) | 2.28276433 |
| 92 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.28027576 |
| 93 | regulation of ARF protein signal transduction (GO:0032012) | 2.27054503 |
| 94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.26756067 |
| 95 | glial cell migration (GO:0008347) | 2.24816254 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.22324705 |
| 97 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.22111644 |
| 98 | L-amino acid import (GO:0043092) | 2.21858353 |
| 99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.21606924 |
| 100 | negative regulation of vascular permeability (GO:0043116) | 2.21253842 |
| 101 | bone resorption (GO:0045453) | 2.20452145 |
| 102 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.20417075 |
| 103 | cellular response to ethanol (GO:0071361) | 2.20059337 |
| 104 | layer formation in cerebral cortex (GO:0021819) | 2.19754673 |
| 105 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.18327171 |
| 106 | regulation of macrophage cytokine production (GO:0010935) | 2.17513058 |
| 107 | membrane lipid catabolic process (GO:0046466) | 2.17265749 |
| 108 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.16806996 |
| 109 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.15631510 |
| 110 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.15183265 |
| 111 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.15108432 |
| 112 | positive regulation of acute inflammatory response (GO:0002675) | 2.14106070 |
| 113 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.14099201 |
| 114 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.13273650 |
| 115 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.13186760 |
| 116 | response to lipoprotein particle (GO:0055094) | 2.13055248 |
| 117 | cellular response to interferon-alpha (GO:0035457) | 2.12592108 |
| 118 | cellular sodium ion homeostasis (GO:0006883) | 2.11986081 |
| 119 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.11687302 |
| 120 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.11499760 |
| 121 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.11208402 |
| 122 | regulation of synaptic vesicle transport (GO:1902803) | 2.10217476 |
| 123 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.10053349 |
| 124 | protein localization to endosome (GO:0036010) | 2.09753359 |
| 125 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.08737015 |
| 126 | response to nerve growth factor (GO:1990089) | 2.07907577 |
| 127 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.07907577 |
| 128 | basement membrane organization (GO:0071711) | 2.07895302 |
| 129 | lymph vessel development (GO:0001945) | 2.07748400 |
| 130 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.07720631 |
| 131 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.07698898 |
| 132 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.06946164 |
| 133 | dendrite morphogenesis (GO:0048813) | 2.06736660 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 2.06651563 |
| 135 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.06109113 |
| 136 | regulation of early endosome to late endosome transport (GO:2000641) | 2.06034618 |
| 137 | positive regulation of cholesterol efflux (GO:0010875) | 2.04608631 |
| 138 | N-acetylneuraminate metabolic process (GO:0006054) | 2.04173275 |
| 139 | low-density lipoprotein particle clearance (GO:0034383) | 2.03307906 |
| 140 | cellular response to interferon-gamma (GO:0071346) | 2.03085588 |
| 141 | amino acid import (GO:0043090) | 2.02546448 |
| 142 | dendritic cell differentiation (GO:0097028) | 2.00619600 |
| 143 | regulation of cholesterol storage (GO:0010885) | 1.99378435 |
| 144 | sphingolipid catabolic process (GO:0030149) | 1.99338740 |
| 145 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.99286934 |
| 146 | vesicle transport along microtubule (GO:0047496) | 1.99243437 |
| 147 | eosinophil chemotaxis (GO:0048245) | 1.99007173 |
| 148 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 1.98813602 |
| 149 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 1.98334360 |
| 150 | semaphorin-plexin signaling pathway (GO:0071526) | 1.96646826 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 1.96542479 |
| 152 | nerve growth factor signaling pathway (GO:0038180) | 1.96282169 |
| 153 | establishment of nucleus localization (GO:0040023) | 1.96134557 |
| 154 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.95750427 |
| 155 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 1.95340979 |
| 156 | positive regulation of axon extension (GO:0045773) | 1.94801560 |
| 157 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 1.93348020 |
| 158 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 1.93067083 |
| 159 | relaxation of cardiac muscle (GO:0055119) | 1.93048052 |
| 160 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 1.92907648 |
| 161 | microglial cell activation (GO:0001774) | 1.91772406 |
| 162 | positive regulation of muscle hypertrophy (GO:0014742) | 1.91192530 |
| 163 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 1.91192530 |
| 164 | negative regulation of amino acid transport (GO:0051956) | 1.90389380 |
| 165 | cell adhesion mediated by integrin (GO:0033627) | 1.89897090 |
| 166 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 1.89856235 |
| 167 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 1.89788844 |
| 168 | substrate-dependent cell migration (GO:0006929) | 1.89295953 |
| 169 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 1.89286002 |
| 170 | neurotransmitter secretion (GO:0007269) | 1.89187341 |
| 171 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.89082509 |
| 172 | dendritic spine morphogenesis (GO:0060997) | 1.88964070 |
| 173 | neuromuscular process controlling balance (GO:0050885) | 1.88740563 |
| 174 | macrophage activation (GO:0042116) | 1.88382302 |
| 175 | cAMP biosynthetic process (GO:0006171) | 1.88265190 |
| 176 | positive regulation of p38MAPK cascade (GO:1900745) | 1.87749426 |
| 177 | blood vessel maturation (GO:0001955) | 1.87726900 |
| 178 | regulation of dendritic spine development (GO:0060998) | 1.87502901 |
| 179 | detection of molecule of bacterial origin (GO:0032490) | 1.87104215 |
| 180 | membrane repolarization (GO:0086009) | 1.86831596 |
| 181 | regulation of ARF GTPase activity (GO:0032312) | 1.86713578 |
| 182 | ovulation from ovarian follicle (GO:0001542) | 1.86667735 |
| 183 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.86515597 |
| 184 | adenosine receptor signaling pathway (GO:0001973) | 1.85604771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.96959491 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.79206608 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17643807 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13911754 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13567437 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.13088906 |
| 7 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.12533970 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10543317 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03685510 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03685510 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.98190985 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96174349 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.94670598 |
| 14 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.91980646 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.89935847 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89738048 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84285407 |
| 18 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.81999528 |
| 19 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.77627779 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.77483439 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73945739 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.71673531 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.71001496 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70972856 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.60906002 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59425344 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54228825 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49030282 |
| 29 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48005698 |
| 30 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46042178 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45708134 |
| 32 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45562351 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43808647 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43744774 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43248090 |
| 36 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43060359 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42526786 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.41325020 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40131021 |
| 40 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.36859817 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34594220 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.33048787 |
| 43 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32740873 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29936161 |
| 45 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28226353 |
| 46 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27936368 |
| 47 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27546387 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24129293 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24102086 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24089529 |
| 51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22766941 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21714418 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21028899 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20325798 |
| 55 | RXR_22108803_ChIP-Seq_LS180_Human | 1.20240400 |
| 56 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19650139 |
| 57 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18212114 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18162327 |
| 59 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16917890 |
| 60 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16535110 |
| 61 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16487306 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16283034 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.15650269 |
| 64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15611052 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15110452 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15025267 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14746859 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14746859 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14373497 |
| 70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12987112 |
| 71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11736183 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10805274 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09763047 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09481109 |
| 75 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09336828 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08786288 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08399152 |
| 78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07996866 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06810757 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05989914 |
| 81 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05929375 |
| 82 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05753709 |
| 83 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05009976 |
| 84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04430483 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04278267 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03451394 |
| 87 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03159526 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03074300 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00939867 |
| 90 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00431274 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00266989 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98859886 |
| 93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98266954 |
| 94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97807303 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97747525 |
| 96 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97203135 |
| 97 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96900276 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96346574 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94456505 |
| 100 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94414199 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 0.94188123 |
| 102 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93873905 |
| 103 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93172501 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92531997 |
| 105 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92005164 |
| 106 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91993567 |
| 107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91668169 |
| 108 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.91177626 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90934512 |
| 110 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90888721 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89933224 |
| 112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88518151 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87969699 |
| 114 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87853759 |
| 115 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87435578 |
| 116 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87414860 |
| 117 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86722802 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86332500 |
| 119 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85672714 |
| 120 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.85330436 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85283136 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85283136 |
| 123 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84737444 |
| 124 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84236907 |
| 125 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83529254 |
| 126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83037727 |
| 127 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82965678 |
| 128 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82934625 |
| 129 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81809662 |
| 130 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.81612627 |
| 131 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.81564746 |
| 132 | P300_19829295_ChIP-Seq_ESCs_Human | 0.81540924 |
| 133 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.80144511 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78881479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.28348956 |
| 2 | MP0006082_CNS_inflammation | 3.27872573 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.24905343 |
| 4 | MP0009840_abnormal_foam_cell | 2.92196929 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.61527489 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.59834494 |
| 7 | MP0004858_abnormal_nervous_system | 2.48757592 |
| 8 | MP0010368_abnormal_lymphatic_system | 2.45412767 |
| 9 | MP0005167_abnormal_blood-brain_barrier | 2.43909060 |
| 10 | MP0001958_emphysema | 2.41951086 |
| 11 | MP0006054_spinal_hemorrhage | 2.41672349 |
| 12 | MP0004272_abnormal_basement_membrane | 2.39260571 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.34200569 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.24511902 |
| 15 | MP0003303_peritoneal_inflammation | 2.19794150 |
| 16 | MP0009785_altered_susceptibility_to | 2.07186055 |
| 17 | MP0000920_abnormal_myelination | 2.07048467 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 1.99670766 |
| 19 | MP0008004_abnormal_stomach_pH | 1.98169248 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 1.98151440 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.96246943 |
| 22 | MP0004510_myositis | 1.94582143 |
| 23 | MP0003075_altered_response_to | 1.90601903 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.90416787 |
| 25 | MP0003690_abnormal_glial_cell | 1.77145620 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.75938256 |
| 27 | MP0003436_decreased_susceptibility_to | 1.74536817 |
| 28 | MP0002419_abnormal_innate_immunity | 1.71198230 |
| 29 | MP0001790_abnormal_immune_system | 1.71053608 |
| 30 | MP0005387_immune_system_phenotype | 1.71053608 |
| 31 | MP0003045_fibrosis | 1.70057825 |
| 32 | MP0009764_decreased_sensitivity_to | 1.67962592 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.67962043 |
| 34 | MP0004130_abnormal_muscle_cell | 1.67866748 |
| 35 | MP0005670_abnormal_white_adipose | 1.65970271 |
| 36 | MP0003279_aneurysm | 1.65888545 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.60428769 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.58907945 |
| 39 | MP0000604_amyloidosis | 1.57439392 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.56762467 |
| 41 | MP0002063_abnormal_learning/memory/cond | 1.56139311 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.54575787 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.54379048 |
| 44 | MP0002064_seizures | 1.52387657 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.51192455 |
| 46 | MP0005275_abnormal_skin_tensile | 1.43998846 |
| 47 | MP0000751_myopathy | 1.40915607 |
| 48 | MP0005503_abnormal_tendon_morphology | 1.40551501 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.40050658 |
| 50 | MP0005025_abnormal_response_to | 1.38766640 |
| 51 | MP0009745_abnormal_behavioral_response | 1.38039898 |
| 52 | MP0003329_amyloid_beta_deposits | 1.36193913 |
| 53 | MP0003724_increased_susceptibility_to | 1.36140193 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.34643752 |
| 55 | MP0003448_altered_tumor_morphology | 1.34605407 |
| 56 | MP0009046_muscle_twitch | 1.33619785 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.30073795 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.26936398 |
| 59 | MP0004484_altered_response_of | 1.26546611 |
| 60 | MP0003633_abnormal_nervous_system | 1.23491299 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.22391514 |
| 62 | MP0002168_other_aberrant_phenotype | 1.22335987 |
| 63 | MP0003828_pulmonary_edema | 1.22164013 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.21161870 |
| 65 | MP0004270_analgesia | 1.20152971 |
| 66 | MP0000343_altered_response_to | 1.19423509 |
| 67 | MP0001968_abnormal_touch/_nociception | 1.18284375 |
| 68 | MP0001542_abnormal_bone_strength | 1.16204367 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.16018348 |
| 70 | MP0005671_abnormal_response_to | 1.15777147 |
| 71 | MP0003091_abnormal_cell_migration | 1.15674399 |
| 72 | MP0003880_abnormal_central_pattern | 1.14108417 |
| 73 | MP0005451_abnormal_body_composition | 1.13928941 |
| 74 | MP0005166_decreased_susceptibility_to | 1.12893534 |
| 75 | MP0002572_abnormal_emotion/affect_behav | 1.12363868 |
| 76 | MP0002452_abnormal_antigen_presenting | 1.12315289 |
| 77 | MP0002896_abnormal_bone_mineralization | 1.10221493 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 1.09561152 |
| 79 | MP0004947_skin_inflammation | 1.06896433 |
| 80 | MP0005257_abnormal_intraocular_pressure | 1.06273317 |
| 81 | MP0000685_abnormal_immune_system | 1.04635159 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 1.02918856 |
| 83 | MP0001765_abnormal_ion_homeostasis | 1.02158628 |
| 84 | MP0005595_abnormal_vascular_smooth | 1.01342931 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.01089409 |
| 86 | MP0010386_abnormal_urinary_bladder | 1.00802085 |
| 87 | MP0004043_abnormal_pH_regulation | 1.00589339 |
| 88 | MP0002723_abnormal_immune_serum | 1.00244943 |
| 89 | MP0002736_abnormal_nociception_after | 0.99586369 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.98182899 |
| 91 | MP0001486_abnormal_startle_reflex | 0.97903667 |
| 92 | MP0001756_abnormal_urination | 0.97795521 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.97666239 |
| 94 | MP0008469_abnormal_protein_level | 0.97128451 |
| 95 | MP0001440_abnormal_grooming_behavior | 0.96876976 |
| 96 | MP0003879_abnormal_hair_cell | 0.94887080 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.94482857 |
| 98 | MP0005310_abnormal_salivary_gland | 0.94245607 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.93275052 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.93046070 |
| 101 | MP0006138_congestive_heart_failure | 0.92722574 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.92371751 |
| 103 | MP0003632_abnormal_nervous_system | 0.92212338 |
| 104 | MP0005535_abnormal_body_temperature | 0.91617599 |
| 105 | MP0001533_abnormal_skeleton_physiology | 0.90582785 |
| 106 | MP0001853_heart_inflammation | 0.89788593 |
| 107 | MP0001545_abnormal_hematopoietic_system | 0.89720956 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 0.89720956 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.89151883 |
| 110 | MP0005023_abnormal_wound_healing | 0.88993620 |
| 111 | MP0003283_abnormal_digestive_organ | 0.87964117 |
| 112 | MP0004036_abnormal_muscle_relaxation | 0.87739076 |
| 113 | MP0002108_abnormal_muscle_morphology | 0.87635904 |
| 114 | MP0008775_abnormal_heart_ventricle | 0.87508021 |
| 115 | MP0005164_abnormal_response_to | 0.87233935 |
| 116 | MP0005390_skeleton_phenotype | 0.86918596 |
| 117 | MP0003634_abnormal_glial_cell | 0.84611107 |
| 118 | MP0003195_calcinosis | 0.83884918 |
| 119 | MP0005620_abnormal_muscle_contractility | 0.83389751 |
| 120 | MP0004883_abnormal_blood_vessel | 0.83376285 |
| 121 | MP0002735_abnormal_chemical_nociception | 0.83321208 |
| 122 | MP0003631_nervous_system_phenotype | 0.81999146 |
| 123 | MP0010155_abnormal_intestine_physiology | 0.81840534 |
| 124 | MP0005377_hearing/vestibular/ear_phenot | 0.81768453 |
| 125 | MP0003878_abnormal_ear_physiology | 0.81768453 |
| 126 | MP0001177_atelectasis | 0.80666612 |
| 127 | MP0005388_respiratory_system_phenotype | 0.80471105 |
| 128 | MP0002133_abnormal_respiratory_system | 0.80471105 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.79117272 |
| 130 | MP0005165_increased_susceptibility_to | 0.79067186 |
| 131 | MP0002090_abnormal_vision | 0.78464688 |
| 132 | MP0008874_decreased_physiological_sensi | 0.77683727 |
| 133 | MP0009278_abnormal_bone_marrow | 0.76816431 |
| 134 | MP0001800_abnormal_humoral_immune | 0.75140450 |
| 135 | MP0002136_abnormal_kidney_physiology | 0.75066957 |
| 136 | MP0002405_respiratory_system_inflammati | 0.74669876 |
| 137 | MP0008260_abnormal_autophagy | 0.74357752 |
| 138 | MP0005248_abnormal_Harderian_gland | 0.74218869 |
| 139 | MP0001299_abnormal_eye_distance/ | 0.74049847 |
| 140 | MP0004811_abnormal_neuron_physiology | 0.73622388 |
| 141 | MP0001544_abnormal_cardiovascular_syste | 0.72696657 |
| 142 | MP0000249_abnormal_blood_vessel | 0.71573181 |
| 143 | MP0001915_intracranial_hemorrhage | 0.67421666 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.64548420 |
| 145 | MP0001819_abnormal_immune_cell | 0.64509496 |
| 146 | MP0002420_abnormal_adaptive_immunity | 0.62955857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Disinhibition (HP:0000734) | 4.06503149 |
| 2 | Nuclear cataract (HP:0100018) | 3.88019748 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.24258031 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 3.24117876 |
| 5 | Apathy (HP:0000741) | 3.22780465 |
| 6 | Broad metatarsal (HP:0001783) | 3.21664978 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.09175495 |
| 8 | Complement deficiency (HP:0004431) | 3.05600940 |
| 9 | Diminished motivation (HP:0000745) | 3.00427107 |
| 10 | Increased circulating renin level (HP:0000848) | 2.80717770 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 2.75502327 |
| 12 | Dysostosis multiplex (HP:0000943) | 2.74430889 |
| 13 | Lymphangioma (HP:0100764) | 2.73249918 |
| 14 | Hematochezia (HP:0002573) | 2.72039372 |
| 15 | Focal motor seizures (HP:0011153) | 2.69114487 |
| 16 | Mucopolysacchariduria (HP:0008155) | 2.68377087 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68377087 |
| 18 | Spontaneous hematomas (HP:0007420) | 2.66673236 |
| 19 | Orchitis (HP:0100796) | 2.62757834 |
| 20 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.61653844 |
| 21 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.58465963 |
| 22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.58465963 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.58465963 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 2.58363885 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.56086261 |
| 26 | Metabolic alkalosis (HP:0200114) | 2.56022172 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 2.55685360 |
| 28 | Optic neuritis (HP:0100653) | 2.55685360 |
| 29 | Myokymia (HP:0002411) | 2.53330962 |
| 30 | Arterial tortuosity (HP:0005116) | 2.51451745 |
| 31 | Inappropriate behavior (HP:0000719) | 2.48271718 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.47893383 |
| 33 | Vascular tortuosity (HP:0004948) | 2.47292001 |
| 34 | Focal seizures (HP:0007359) | 2.46128781 |
| 35 | Protrusio acetabuli (HP:0003179) | 2.45826421 |
| 36 | Shallow orbits (HP:0000586) | 2.45591806 |
| 37 | Hypokalemic alkalosis (HP:0001949) | 2.45496605 |
| 38 | Aortic aneurysm (HP:0004942) | 2.40895688 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.38569182 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35596765 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.33795243 |
| 42 | Abnormality of complement system (HP:0005339) | 2.32499636 |
| 43 | Amyloidosis (HP:0011034) | 2.31393438 |
| 44 | Action tremor (HP:0002345) | 2.30595816 |
| 45 | Axonal loss (HP:0003447) | 2.29549801 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.27702108 |
| 47 | Supranuclear gaze palsy (HP:0000605) | 2.24194568 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.23875782 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.22198247 |
| 50 | Premature rupture of membranes (HP:0001788) | 2.19517537 |
| 51 | Striae distensae (HP:0001065) | 2.19173827 |
| 52 | Hyperactive renin-angiotensin system (HP:0000841) | 2.18045291 |
| 53 | Cervical subluxation (HP:0003308) | 2.15269619 |
| 54 | Agnosia (HP:0010524) | 2.14251288 |
| 55 | Aortic dissection (HP:0002647) | 2.12754067 |
| 56 | Dementia (HP:0000726) | 2.12099893 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.08083078 |
| 58 | Polyuria (HP:0000103) | 2.06623561 |
| 59 | Abnormal eating behavior (HP:0100738) | 2.06499460 |
| 60 | Abnormal urine output (HP:0012590) | 2.00831989 |
| 61 | Myositis (HP:0100614) | 2.00184526 |
| 62 | Mitral valve prolapse (HP:0001634) | 2.00160019 |
| 63 | Dilatation of the ascending aorta (HP:0005111) | 1.99909477 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 1.98415412 |
| 65 | Basal ganglia calcification (HP:0002135) | 1.97930117 |
| 66 | Memory impairment (HP:0002354) | 1.97796718 |
| 67 | Mitral stenosis (HP:0001718) | 1.96861774 |
| 68 | Thin bony cortex (HP:0002753) | 1.96503734 |
| 69 | Hydroxyprolinuria (HP:0003080) | 1.91185231 |
| 70 | Abnormality of proline metabolism (HP:0010907) | 1.91185231 |
| 71 | Enlarged penis (HP:0000040) | 1.89624289 |
| 72 | Overgrowth (HP:0001548) | 1.88985126 |
| 73 | Progressive neurologic deterioration (HP:0002344) | 1.87672610 |
| 74 | Abnormality of renal excretion (HP:0011036) | 1.87415886 |
| 75 | Postural instability (HP:0002172) | 1.86788498 |
| 76 | Upper motor neuron abnormality (HP:0002127) | 1.84822052 |
| 77 | Abnormal drinking behavior (HP:0030082) | 1.84232916 |
| 78 | Polydipsia (HP:0001959) | 1.84232916 |
| 79 | Aneurysm (HP:0002617) | 1.83927484 |
| 80 | Pulmonary artery stenosis (HP:0004415) | 1.83542317 |
| 81 | Neurofibrillary tangles (HP:0002185) | 1.81513646 |
| 82 | Pulmonary infiltrates (HP:0002113) | 1.81386479 |
| 83 | Zonular cataract (HP:0010920) | 1.80935379 |
| 84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.80215217 |
| 85 | Hemiplegia (HP:0002301) | 1.79695980 |
| 86 | Metaphyseal irregularity (HP:0003025) | 1.78889597 |
| 87 | Peripheral demyelination (HP:0011096) | 1.78196930 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77747575 |
| 89 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77747575 |
| 90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77747575 |
| 91 | Abnormality of chloride homeostasis (HP:0011422) | 1.76786654 |
| 92 | Torticollis (HP:0000473) | 1.76158608 |
| 93 | Tetraparesis (HP:0002273) | 1.75511895 |
| 94 | Turricephaly (HP:0000262) | 1.75442757 |
| 95 | Absent frontal sinuses (HP:0002688) | 1.75032421 |
| 96 | Conjunctival telangiectasia (HP:0000524) | 1.74711963 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 1.74446107 |
| 98 | Personality changes (HP:0000751) | 1.74038332 |
| 99 | Abnormality of the periventricular white matter (HP:0002518) | 1.73335609 |
| 100 | Spastic tetraparesis (HP:0001285) | 1.73218759 |
| 101 | Generalized tonic-clonic seizures (HP:0002069) | 1.73066580 |
| 102 | Rapidly progressive (HP:0003678) | 1.73031487 |
| 103 | Spondylolisthesis (HP:0003302) | 1.72289133 |
| 104 | Mutism (HP:0002300) | 1.71965867 |
| 105 | Bladder diverticulum (HP:0000015) | 1.70739706 |
| 106 | Distal upper limb amyotrophy (HP:0007149) | 1.70699157 |
| 107 | Upper limb amyotrophy (HP:0009129) | 1.70699157 |
| 108 | Pathologic fracture (HP:0002756) | 1.69820366 |
| 109 | Global brain atrophy (HP:0002283) | 1.69666819 |
| 110 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.69564811 |
| 111 | Glomerulonephritis (HP:0000099) | 1.69430457 |
| 112 | Esophageal varix (HP:0002040) | 1.69413562 |
| 113 | Ovoid vertebral bodies (HP:0003300) | 1.68331992 |
| 114 | Increased CSF protein (HP:0002922) | 1.66781740 |
| 115 | Hypoplasia of the iris (HP:0007676) | 1.66539519 |
| 116 | Gingivitis (HP:0000230) | 1.66432117 |
| 117 | Keratoconjunctivitis sicca (HP:0001097) | 1.65980154 |
| 118 | Abnormality of renin-angiotensin system (HP:0000847) | 1.65702918 |
| 119 | Skin nodule (HP:0200036) | 1.65652126 |
| 120 | Purpura (HP:0000979) | 1.65581500 |
| 121 | Bone pain (HP:0002653) | 1.64536599 |
| 122 | Visual hallucinations (HP:0002367) | 1.64533808 |
| 123 | Hand muscle atrophy (HP:0009130) | 1.64075009 |
| 124 | Papilledema (HP:0001085) | 1.63687728 |
| 125 | Nephritis (HP:0000123) | 1.63532136 |
| 126 | Epileptic encephalopathy (HP:0200134) | 1.63528087 |
| 127 | Abnormality of the nasal mucosa (HP:0000433) | 1.63394403 |
| 128 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.62592534 |
| 129 | Neuronal loss in central nervous system (HP:0002529) | 1.61364887 |
| 130 | Hemoptysis (HP:0002105) | 1.60850262 |
| 131 | Peripheral hypomyelination (HP:0007182) | 1.60001790 |
| 132 | Macroorchidism (HP:0000053) | 1.59794398 |
| 133 | Protuberant abdomen (HP:0001538) | 1.59409683 |
| 134 | Polyphagia (HP:0002591) | 1.58766004 |
| 135 | Myocardial infarction (HP:0001658) | 1.58297423 |
| 136 | Impaired social interactions (HP:0000735) | 1.58170110 |
| 137 | Abnormal social behavior (HP:0012433) | 1.58170110 |
| 138 | Prolonged neonatal jaundice (HP:0006579) | 1.57709210 |
| 139 | Abnormality of binocular vision (HP:0011514) | 1.57158175 |
| 140 | Diplopia (HP:0000651) | 1.57158175 |
| 141 | Urinary incontinence (HP:0000020) | 1.56222463 |
| 142 | Ankle contracture (HP:0006466) | 1.56091396 |
| 143 | Buphthalmos (HP:0000557) | 1.55801815 |
| 144 | Postural tremor (HP:0002174) | 1.55666506 |
| 145 | Poor eye contact (HP:0000817) | 1.54602766 |
| 146 | Follicular hyperkeratosis (HP:0007502) | 1.53885910 |
| 147 | Hyperaldosteronism (HP:0000859) | 1.53470872 |
| 148 | Mesangial abnormality (HP:0001966) | 1.53430796 |
| 149 | Gout (HP:0001997) | 1.53415017 |
| 150 | J-shaped sella turcica (HP:0002680) | 1.53222755 |
| 151 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.52219219 |
| 152 | Loss of speech (HP:0002371) | 1.51889911 |
| 153 | Osteopenia (HP:0000938) | 1.51196004 |
| 154 | Retinal atrophy (HP:0001105) | 1.50069528 |
| 155 | Polygenic inheritance (HP:0010982) | 1.49234765 |
| 156 | Autoimmune thrombocytopenia (HP:0001973) | 1.48790102 |
| 157 | Hypomagnesemia (HP:0002917) | 1.47800047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 3.03680585 |
| 2 | IRAK3 | 3.02901279 |
| 3 | GRK7 | 2.89775557 |
| 4 | EPHA4 | 2.68990521 |
| 5 | PRKD3 | 2.66861613 |
| 6 | NTRK3 | 2.34540775 |
| 7 | TGFBR2 | 2.24724132 |
| 8 | RIPK4 | 2.23567790 |
| 9 | TRIB3 | 2.17556177 |
| 10 | MAP3K14 | 2.15144711 |
| 11 | RIPK1 | 2.11457182 |
| 12 | BLK | 2.04426831 |
| 13 | DAPK2 | 1.98200443 |
| 14 | MAP3K9 | 1.97179655 |
| 15 | PTK2B | 1.80526362 |
| 16 | CAMK1G | 1.73080706 |
| 17 | WNK4 | 1.70189810 |
| 18 | TAOK2 | 1.64511696 |
| 19 | CAMK1D | 1.62847730 |
| 20 | CAMKK1 | 1.61979538 |
| 21 | CDC42BPA | 1.58839623 |
| 22 | NTRK1 | 1.58333562 |
| 23 | EPHA3 | 1.58299811 |
| 24 | KSR2 | 1.54441715 |
| 25 | ERN1 | 1.53905136 |
| 26 | MATK | 1.50316947 |
| 27 | PDGFRA | 1.50110222 |
| 28 | MAP3K4 | 1.49742321 |
| 29 | PAK6 | 1.48126766 |
| 30 | SIK2 | 1.42772019 |
| 31 | MINK1 | 1.39843009 |
| 32 | KDR | 1.39706746 |
| 33 | NEK9 | 1.39257513 |
| 34 | BMPR2 | 1.29312332 |
| 35 | BMX | 1.29298659 |
| 36 | STK38 | 1.29168788 |
| 37 | DMPK | 1.28555178 |
| 38 | CSK | 1.28517833 |
| 39 | PRKCH | 1.28373271 |
| 40 | DDR2 | 1.24744970 |
| 41 | JAK1 | 1.21327392 |
| 42 | WNK3 | 1.18764946 |
| 43 | SIK1 | 1.14008962 |
| 44 | IKBKE | 1.12801627 |
| 45 | SGK3 | 1.12309226 |
| 46 | IRAK1 | 1.10985045 |
| 47 | LMTK2 | 1.10907155 |
| 48 | MAP2K4 | 1.10765426 |
| 49 | RET | 1.08532721 |
| 50 | PKN2 | 1.07827580 |
| 51 | FES | 1.06523114 |
| 52 | MAP3K13 | 1.05876679 |
| 53 | IRAK2 | 1.03525771 |
| 54 | OXSR1 | 1.00951091 |
| 55 | ADRBK2 | 0.99962949 |
| 56 | FGFR4 | 0.99720913 |
| 57 | PDK2 | 0.98845110 |
| 58 | NTRK2 | 0.97330486 |
| 59 | PDPK1 | 0.96351645 |
| 60 | LATS2 | 0.95179500 |
| 61 | ABL2 | 0.95066946 |
| 62 | ARAF | 0.92386267 |
| 63 | PDK1 | 0.91741184 |
| 64 | PDK3 | 0.91295624 |
| 65 | PDK4 | 0.91295624 |
| 66 | PLK2 | 0.91105529 |
| 67 | MAP3K2 | 0.90734026 |
| 68 | ROCK2 | 0.89777059 |
| 69 | KSR1 | 0.89523423 |
| 70 | CDK5 | 0.89515107 |
| 71 | SGK2 | 0.88719161 |
| 72 | FER | 0.86400927 |
| 73 | MAPK7 | 0.84787137 |
| 74 | PIM2 | 0.82926062 |
| 75 | SGK223 | 0.82314567 |
| 76 | SGK494 | 0.82314567 |
| 77 | PTK6 | 0.82032421 |
| 78 | PRPF4B | 0.81406227 |
| 79 | IKBKB | 0.81344259 |
| 80 | CAMKK2 | 0.80623129 |
| 81 | MAPK12 | 0.78767070 |
| 82 | MAP3K3 | 0.75824212 |
| 83 | JAK3 | 0.75588651 |
| 84 | WNK1 | 0.75114747 |
| 85 | SCYL2 | 0.74852566 |
| 86 | GRK5 | 0.73510589 |
| 87 | MAP2K7 | 0.73282224 |
| 88 | PDGFRB | 0.72810392 |
| 89 | CAMK1 | 0.72809682 |
| 90 | CAMK4 | 0.72308301 |
| 91 | TTN | 0.72069552 |
| 92 | FGFR2 | 0.70649224 |
| 93 | MARK1 | 0.70517496 |
| 94 | MAP3K11 | 0.69760799 |
| 95 | FGFR3 | 0.69636646 |
| 96 | DAPK1 | 0.67298995 |
| 97 | PKN1 | 0.66971643 |
| 98 | SGK1 | 0.66662223 |
| 99 | CHUK | 0.66384112 |
| 100 | CDK6 | 0.63851468 |
| 101 | PHKG2 | 0.60751560 |
| 102 | PHKG1 | 0.60751560 |
| 103 | CDK15 | 0.60543216 |
| 104 | MAP3K1 | 0.59547928 |
| 105 | EPHB2 | 0.59498274 |
| 106 | PRKCG | 0.59419470 |
| 107 | SIK3 | 0.59362263 |
| 108 | INSRR | 0.59132031 |
| 109 | ACVR1B | 0.58855958 |
| 110 | MAP3K7 | 0.58305578 |
| 111 | ZAP70 | 0.57654526 |
| 112 | TYRO3 | 0.57474249 |
| 113 | RPS6KA2 | 0.57218477 |
| 114 | STK11 | 0.56523180 |
| 115 | JAK2 | 0.56130163 |
| 116 | MOS | 0.56080477 |
| 117 | CDK18 | 0.55956854 |
| 118 | PRKCE | 0.54746488 |
| 119 | MAPK4 | 0.54022310 |
| 120 | IRAK4 | 0.53017510 |
| 121 | TBK1 | 0.52123594 |
| 122 | FGR | 0.52040698 |
| 123 | PRKD1 | 0.50959069 |
| 124 | CDK14 | 0.50175957 |
| 125 | FYN | 0.50156741 |
| 126 | TNIK | 0.50137120 |
| 127 | EPHB1 | 0.50066881 |
| 128 | MAP2K1 | 0.49886122 |
| 129 | NME2 | 0.49668253 |
| 130 | TESK1 | 0.49551847 |
| 131 | CDK11A | 0.48876092 |
| 132 | CAMK2B | 0.48573885 |
| 133 | CASK | 0.47735721 |
| 134 | ROCK1 | 0.47511122 |
| 135 | TYK2 | 0.47044188 |
| 136 | EGFR | 0.47023455 |
| 137 | MARK2 | 0.47012981 |
| 138 | PAK3 | 0.46996385 |
| 139 | MAP3K5 | 0.46711491 |
| 140 | KIT | 0.46458201 |
| 141 | SRC | 0.46222057 |
| 142 | YES1 | 0.45815111 |
| 143 | TAOK1 | 0.44539273 |
| 144 | PTK2 | 0.43933839 |
| 145 | FRK | 0.43720251 |
| 146 | UHMK1 | 0.42595229 |
| 147 | CSF1R | 0.42169311 |
| 148 | CAMK2G | 0.40251460 |
| 149 | GSK3A | 0.38437600 |
| 150 | ABL1 | 0.38337533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89557578 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.76062631 |
| 3 | Asthma_Homo sapiens_hsa05310 | 1.72400735 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70680284 |
| 5 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.70629744 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 1.63259565 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61273121 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48846705 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.44959865 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.42945377 |
| 11 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.42752769 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36893852 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 1.36466260 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.35413913 |
| 15 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.35000376 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.34368606 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.33464490 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31615013 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.29307289 |
| 20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28873555 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28192053 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.27343793 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.25732638 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21539050 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21491021 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21013596 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.19986345 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17727893 |
| 29 | Glioma_Homo sapiens_hsa05214 | 1.17066553 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.16740915 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15937451 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15915958 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15906446 |
| 34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.12966714 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.12732468 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12237488 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.11715709 |
| 38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.08346354 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.07894176 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07560596 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07339338 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.06021973 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.05506620 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04657331 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.03647384 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03356395 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00019960 |
| 48 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99829138 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96673252 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.95181160 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 0.93718652 |
| 52 | Focal adhesion_Homo sapiens_hsa04510 | 0.93047175 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.92477605 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91949865 |
| 55 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.91719123 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91402822 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91013191 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90867687 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89739200 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89305107 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89101965 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88145648 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87864258 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86286747 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85749677 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85147358 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84864457 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83118592 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.81844285 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80483367 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80067123 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79568586 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79407316 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78428986 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78094945 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77750016 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77398464 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.75362569 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74996871 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.74631061 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74500880 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74237239 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.74044495 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73464360 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73104792 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.73023322 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72655613 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72260483 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71977702 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.71931374 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71681779 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71677773 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71395187 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71014464 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70299150 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69856971 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69788057 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69638601 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69489949 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69398878 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69012232 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68937630 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.68822260 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.68643193 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.67992075 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.67563114 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66639930 |
| 108 | Axon guidance_Homo sapiens_hsa04360 | 0.66497902 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.65605538 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.65546291 |
| 111 | Long-term depression_Homo sapiens_hsa04730 | 0.65177257 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.63407795 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63249116 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60314267 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60003815 |
| 116 | Melanogenesis_Homo sapiens_hsa04916 | 0.59997695 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.59492186 |
| 118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.59232312 |
| 119 | Shigellosis_Homo sapiens_hsa05131 | 0.58908151 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58391040 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58173602 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58094087 |
| 123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57269133 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57090230 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55979102 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55865518 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55255736 |
| 128 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55192782 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.54396791 |
| 130 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49711872 |
| 131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46860616 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46447553 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46179161 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45182370 |
| 135 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42738106 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40475540 |
| 137 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40153317 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.39783232 |

